Nuvalent (NUVL) News Today $92.52 +2.10 (+2.32%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$91.26 -1.26 (-1.36%) As of 10/17/2025 05:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Nuvalent Up Today?Toggle Visibility of Why Is Nuvalent Up Today?Nuvalent, Inc. (NUVL) — Shares moved higher today after fresh analyst coverage and institutional buying pressured the tape upward, while multiple insider stock sales tempered the rally. Below are the items most likely driving the move. Positive Sentiment: New coverage/price targets — Cantor Fitzgerald initiated coverage at Overweight and cited roughly 60% upside, and Stifel Nicolaus reiterated/affirmed a Buy with a $115 target; both boost buy-side interest and headline demand. Source: MSN — Cantor Source: MarketBeat — Stifel Positive Sentiment: Institutional accumulation — MarketBeat notes recent institutional buys and position increases (Voya, BNP Paribas among others), which supports demand and liquidity for the stock. Source: MarketBeat Neutral Sentiment: Analyst momentum overall — multiple firms (Leerink, Piper Sandler, Raymond James, Wedbush) maintain Outperform/Overweight views and higher targets, lifting consensus sentiment even as a small subset remains bearish. Source: MarketBeat Negative Sentiment: Executive and insider selling — CFO Alexandra Balcom sold large blocks (20,000 shares on Oct 13 at ~$88.51 and an additional 1,683 on Oct 15), and insider Henry Pelish sold multiple tranches (7,637 and 2,433 shares). These disclosures (SEC filings) can create short‑term selling pressure or raise governance questions for some investors. Balcom sale (MarketBeat) SEC filing Bottom line for investors: bullish analyst coverage and institutional inflows appear to be the main drivers of the stock’s uptick today; however, sizeable insider liquidation is a cautionary signal that could cap near-term gains.Posted 1+ days agoAI Generated. May Contain Errors. NUVL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Nuvalent (NASDAQ:NUVL) CFO Alexandra Balcom Sells 1,683 Shares1 hour ago | marketbeat.comNuvalent Presents Preliminary Data for Neladalkib in Advanced ALK-positive Solid Tumors Beyond NSCLC at ESMO 2025October 18 at 6:00 AM | prnewswire.comAlexandra Balcom Sells 1,683 Shares of Nuvalent (NASDAQ:NUVL) StockOctober 18 at 5:58 AM | insidertrades.comNuvalent, Inc. (NASDAQ:NUVL) Given Consensus Rating of "Moderate Buy" by BrokeragesOctober 18 at 2:09 AM | americanbankingnews.comNuvalent, Inc. (NASDAQ:NUVL) Receives Average Rating of "Moderate Buy" from AnalystsOctober 18 at 2:07 AM | marketbeat.comStifel Reiterates Nuvalent (NUVL) Buy RecommendationOctober 17 at 2:20 AM | msn.comNuvalent (NASDAQ:NUVL) Insider Sells $208,702.74 in StockOctober 16 at 7:42 PM | marketbeat.comNuvalent (NASDAQ:NUVL) Insider Henry Pelish Sells 7,637 SharesOctober 16 at 7:17 PM | marketbeat.comAlexandra Balcom Sells 20,000 Shares of Nuvalent (NASDAQ:NUVL) StockOctober 16 at 7:16 PM | marketbeat.comNuvalent (NASDAQ:NUVL) Receives Buy Rating from Stifel NicolausOctober 16 at 10:12 AM | marketbeat.comNuvalent (NASDAQ:NUVL) Insider Sells $208,702.74 in StockOctober 16 at 5:25 AM | insidertrades.comCantor starts Nuvalent at Overweight, sees 60% potential upsideOctober 16 at 5:14 AM | msn.comCantor Fitzgerald Initiates Coverage of Nuvalent (NUVL) with Overweight RecommendationOctober 16 at 5:14 AM | msn.comCantor Fitzgerald Initiates Coverage on Nuvalent (NASDAQ:NUVL)October 15 at 9:27 AM | marketbeat.comNuvalent (NASDAQ:NUVL) Trading Down 4.8% - Here's What HappenedOctober 14, 2025 | marketbeat.comNuvalent to Present New Preclinical Data for HER2-Selective Inhibitor, NVL-330, at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsOctober 13, 2025 | prnewswire.comNuvalent (NASDAQ:NUVL) Earns "Sell (D-)" Rating from Weiss RatingsOctober 10, 2025 | marketbeat.comNuvalent, Inc. Stock (NUVL) Opinions on Cancer Therapy Developments and Insider SaleOctober 2, 2025 | quiverquant.comQNuvalent (NASDAQ:NUVL) CFO Sells $645,055.88 in StockOctober 2, 2025 | insidertrades.comNuvalent (NASDAQ:NUVL) CFO Alexandra Balcom Sells 7,588 SharesOctober 1, 2025 | marketbeat.comNuvalent, Inc. (NUVL) Presents at UBS Virtual Oncology Day TranscriptOctober 1, 2025 | seekingalpha.comNuvalent to Participate in the UBS 2025 Virtual Oncology DaySeptember 24, 2025 | prnewswire.com5,700 Shares in Nuvalent, Inc. $NUVL Acquired by Strs OhioSeptember 23, 2025 | marketbeat.comNuvalent, Inc. (NASDAQ:NUVL) Receives Average Rating of "Buy" from AnalystsSeptember 23, 2025 | marketbeat.comNuvalent Completes New Drug Application SubmissionSeptember 22, 2025 | tipranks.comNuvalent (NASDAQ:NUVL) CEO Sells $2,135,160.00 in StockSeptember 18, 2025 | marketbeat.comJames Richard Porter Sells 27,000 Shares of Nuvalent (NASDAQ:NUVL) StockSeptember 18, 2025 | insidertrades.comVoya Investment Management LLC Has $8.53 Million Holdings in Nuvalent, Inc. $NUVLSeptember 18, 2025 | marketbeat.comNuvalent (NUVL): Assessing Valuation Following Subtle Shifts in Investor SentimentSeptember 17, 2025 | finance.yahoo.comNuvalent (NASDAQ:NUVL) Insider Henry Pelish Sells 3,725 SharesSeptember 14, 2025 | marketbeat.comNuvalent (NASDAQ:NUVL) Insider Sells $293,641.75 in StockSeptember 13, 2025 | insidertrades.com20,994 Shares in Nuvalent, Inc. $NUVL Bought by Voleon Capital Management LPSeptember 11, 2025 | marketbeat.comFred Alger Management LLC Cuts Stake in Nuvalent, Inc. $NUVLSeptember 11, 2025 | marketbeat.comNuvalent's (NUVL) Outperform Rating Reaffirmed at WedbushSeptember 10, 2025 | marketbeat.comPolar Asset Management Partners Inc. Reduces Stock Holdings in Nuvalent, Inc. $NUVLSeptember 9, 2025 | marketbeat.comNuvalent, Inc. $NUVL Shares Bought by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comNuvalent, Inc. $NUVL Shares Sold by Alyeska Investment Group L.P.September 8, 2025 | marketbeat.comNuvalent presents data from ARROS-1 trial of zidesamtinibSeptember 7, 2025 | msn.comAdage Capital Partners GP L.L.C. Reduces Holdings in Nuvalent, Inc. $NUVLSeptember 7, 2025 | marketbeat.comNuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025September 7, 2025 | prnewswire.comNuvalent (NASDAQ:NUVL) Now Covered by Analysts at GuggenheimSeptember 6, 2025 | marketbeat.comNuvalent, Inc. $NUVL is Vestal Point Capital LP's 4th Largest PositionSeptember 4, 2025 | marketbeat.comRaymond James Initiates Coverage of Nuvalent (NUVL) with Outperform RecommendationSeptember 4, 2025 | msn.comNuvalent initiated with an Outperform at Raymond JamesSeptember 4, 2025 | msn.comNuvalent assumed with a Buy at GuggenheimSeptember 4, 2025 | msn.comBraidwell LP Has $59.64 Million Stock Position in Nuvalent, Inc. $NUVLSeptember 3, 2025 | marketbeat.comWalleye Capital LLC Lowers Position in Nuvalent, Inc. $NUVLSeptember 3, 2025 | marketbeat.comParadigm Biocapital Advisors LP Trims Stock Position in Nuvalent, Inc. $NUVLSeptember 2, 2025 | marketbeat.comNuvalent, Inc. $NUVL Shares Sold by Northern Trust CorpSeptember 2, 2025 | marketbeat.comPiper Sandler Initiates Nuvalent (NUVL) Amid Key Cancer Drug CatalystsSeptember 2, 2025 | insidermonkey.com Get Nuvalent News Delivered to You Automatically Sign up to receive the latest news and ratings for NUVL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NUVL Media Mentions By Week NUVL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NUVL News Sentiment▼0.030.46▲Average Medical News Sentiment NUVL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NUVL Articles This Week▼277▲NUVL Articles Average Week Get the Latest News and Ratings for NUVL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Nuvalent and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BNTX News Today TEVA News Today GMAB News Today SMMT News Today ASND News Today RDY News Today VTRS News Today ROIV News Today BBIO News Today MRNA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NUVL) was last updated on 10/18/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBlackRock’s Shocking Crypto MoveBlackRock, Fidelity, and JPMorgan have quietly shifted billions out of Bitcoin and into a single emerging cryp...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvalent, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvalent With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.